mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. [electronic resource]
Producer: 20180213Description: 1158-78 p. digitalISSN:- 1573-675X
- Apoptosis -- drug effects
- Autophagy -- drug effects
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Humans
- Male
- Prostatic Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-akt -- genetics
- Purines -- pharmacology
- Receptors, Androgen -- genetics
- Roscovitine
- Signal Transduction -- drug effects
- TOR Serine-Threonine Kinases -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.